Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya

• Gloria Omosa-Manyonyi,

  Affiliation Kenya AIDS Vaccine Initiative Institute of Clinical Research, University of Nairobi, Nairobi, Kenya

  ⨯
• Harriet Park ,

  * E-mail: hpark@iavi.org

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Gaudensia Mutua,

  Affiliation Kenya AIDS Vaccine Initiative Institute of Clinical Research, University of Nairobi, Nairobi, Kenya

  ⨯
• Bashir Farah,

  Affiliation Kenya AIDS Vaccine Initiative Institute of Clinical Research, University of Nairobi, Nairobi, Kenya

  ⨯
• Philip J. Bergin,

  Affiliation IAVI Human Immunology Laboratory, Imperial College London, London, United Kingdom

  ⨯
• Dagna Laufer,

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Jennifer Lehrman,

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Kundai Chinyenze,

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Burc Barin,

  Affiliation EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• Pat Fast,

  Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Jill Gilmour,

  Affiliation IAVI Human Immunology Laboratory, Imperial College London, London, United Kingdom

  ⨯
• Omu Anzala

  Affiliation Kenya AIDS Vaccine Initiative Institute of Clinical Research, University of Nairobi, Nairobi, Kenya

  ⨯